Louis Chen

Stock Analyst at Cantor Fitzgerald

(n/a)

# 4,653

Out of 5,046 analysts

9

Total ratings

11.11%

Success rate

-54.86%

Average return

Main Sectors:

Top Industries:

Medical Devices Biotechnology

Stocks Rated by Louis Chen

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CATX Perspective Therapeutics	Reiterates: Overweight	n/a	$2.73	-	8	Sep 10, 2024
	PCVX Vaxcyte	Reiterates: Overweight	$55	$45.28	+21.47%	1	Feb 24, 2022

Perspective Therapeutics

Sep 10, 2024

Reiterates: Overweight

Price Target: n/a

Current: $2.73

Upside: -

Vaxcyte

Feb 24, 2022

Reiterates: Overweight

Price Target: $55

Current: $45.28

Upside: +21.47%